Breaking News Headlines Today | Ground News

See every side of every news story

healtheconomics.com image

News from healtheconomics.com

healtheconomics.com’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

healtheconomics.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about healtheconomics.com

Where is healtheconomics.com located?healtheconomics.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top healtheconomics.com News

What in the World?

What in the World?

50% Right coverage: 4 sources

Test yourself on the week of Jan. 24: China’s anti-corruption crusade continues, Trump pushes boundaries in Minneapolis, and India and the EU reach a trade…See the Story

Sanofi expects vaccine sales growth to dip amid ‘challenging environment’

Vaccinations · Paris

Sanofi expects vaccine sales growth to dip amid ‘challenging environment’

67% Center coverage: 3 sources

On a conference call, executives cited “confusion” and declining vaccination rates in the U.S. while discussing a quarterly sales decline and anticipated slower growth in 2026.See the Story

FDA Launches ‘PreCheck’ Program; AstraZeneca, Acadia Drugs Set Back

United States · United States

FDA Launches ‘PreCheck’ Program; AstraZeneca, Acadia Drugs Set Back

100% Center coverage: 1 sources

The agency’s program will be open to pharmaceutical facilities that align with “national priorities.” Elsewhere, a self-administered lupus drug was turned back and MeiraGTx picked up another gene therapy.See the Story

Breaking News Topics Related to healtheconomics.com